Catalyst Wire Dossier Catalyst Wire Dossier

TQF3250 capsules

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQF3250 capsules, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects [Phase 1]

See pricing